KR890014743A - 성장인자 활성을 가진 신규의 폴리펩티드 및 그 폴리펩티드를 코드화한 아미노산 배열 - Google Patents
성장인자 활성을 가진 신규의 폴리펩티드 및 그 폴리펩티드를 코드화한 아미노산 배열 Download PDFInfo
- Publication number
- KR890014743A KR890014743A KR1019890003761A KR890003761A KR890014743A KR 890014743 A KR890014743 A KR 890014743A KR 1019890003761 A KR1019890003761 A KR 1019890003761A KR 890003761 A KR890003761 A KR 890003761A KR 890014743 A KR890014743 A KR 890014743A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acid
- region
- polypeptide
- sequence
- dna sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17265388A | 1988-03-24 | 1988-03-24 | |
| US172,653 | 1988-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR890014743A true KR890014743A (ko) | 1989-10-25 |
Family
ID=22628611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019890003761A Withdrawn KR890014743A (ko) | 1988-03-24 | 1989-03-24 | 성장인자 활성을 가진 신규의 폴리펩티드 및 그 폴리펩티드를 코드화한 아미노산 배열 |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPH0279981A (https=) |
| KR (1) | KR890014743A (https=) |
| AU (2) | AU3169589A (https=) |
| BE (1) | BE1004202A5 (https=) |
| CH (1) | CH681081A5 (https=) |
| DE (1) | DE3910084A1 (https=) |
| DK (1) | DK146789A (https=) |
| ES (1) | ES2013408A6 (https=) |
| FI (1) | FI891308L (https=) |
| FR (1) | FR2632321A1 (https=) |
| GB (1) | GB2219799B (https=) |
| GR (1) | GR1000876B (https=) |
| HU (1) | HUT50501A (https=) |
| IE (1) | IE890950L (https=) |
| IL (1) | IL89673A0 (https=) |
| IT (1) | IT1234961B (https=) |
| LU (1) | LU87489A1 (https=) |
| NL (1) | NL8900724A (https=) |
| NO (1) | NO891273D0 (https=) |
| NZ (1) | NZ228427A (https=) |
| PT (1) | PT90118B (https=) |
| SE (1) | SE8901031L (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0293785A3 (en) * | 1987-05-29 | 1990-05-02 | Oncogen Limited Partnership | Cloning and expression of simian transforming growth factor-ss1 |
| EP0444961A1 (en) * | 1990-03-02 | 1991-09-04 | Bristol-Myers Squibb Company | Her3: A novel EGF receptor homolog |
| EP0739984A1 (en) * | 1995-04-26 | 1996-10-30 | San Tumorforschungs-Gmbh | Bivalent polypeptides containing at least two domains |
| WO1997038002A1 (en) * | 1996-04-10 | 1997-10-16 | Human Genome Sciences, Inc. | Extracellular/epidermal growth factor-like protein |
| US6852506B1 (en) | 1996-04-10 | 2005-02-08 | Human Genome Sciences, Inc. | Extracellular/epidermal growth factor-like protein |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0108132A1 (en) * | 1982-05-06 | 1984-05-16 | Applied Molecular Genetics Inc. | The manufacture and expression of genes for urogastrone and polypeptide analogs thereof |
| JPS6028994A (ja) * | 1983-07-08 | 1985-02-14 | Wakunaga Seiyaku Kk | 〔21―ロイシン〕ヒトウロガストロン |
| WO1985002198A1 (en) * | 1983-11-01 | 1985-05-23 | Amgen | Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides |
| JP2554459B2 (ja) * | 1984-07-02 | 1996-11-13 | アース製薬 株式会社 | β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体 |
| JPS62501071A (ja) * | 1984-10-30 | 1987-04-30 | オンコゲン | 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列 |
| GB8507666D0 (en) * | 1985-03-25 | 1985-05-01 | Wellcome Found | Epidermal growth factor production |
| US4743679A (en) * | 1986-02-24 | 1988-05-10 | Creative Biomolecules, Inc. | Process for producing human epidermal growth factor and analogs thereof |
| GB2210618B (en) * | 1987-10-08 | 1991-10-16 | British Bio Technology | Synthetic egf gene |
| JP2970811B2 (ja) * | 1987-10-30 | 1999-11-02 | オンコゲン ア リミテッド パートナーシップ | 原核生物細胞中にポリペプチドを調製するための発現システム |
| EP0314184B1 (en) * | 1987-10-30 | 1995-12-13 | Bristol-Myers Squibb Company | Expression plasmids |
-
1989
- 1989-03-20 IL IL89673A patent/IL89673A0/xx unknown
- 1989-03-20 FI FI891308A patent/FI891308L/fi not_active IP Right Cessation
- 1989-03-21 NZ NZ228427A patent/NZ228427A/xx unknown
- 1989-03-22 ES ES8901049A patent/ES2013408A6/es not_active Expired - Lifetime
- 1989-03-22 DK DK146789A patent/DK146789A/da not_active Application Discontinuation
- 1989-03-22 SE SE8901031A patent/SE8901031L/xx not_active Application Discontinuation
- 1989-03-22 NO NO891273A patent/NO891273D0/no unknown
- 1989-03-23 NL NL8900724A patent/NL8900724A/nl not_active Application Discontinuation
- 1989-03-23 IE IE890950A patent/IE890950L/xx unknown
- 1989-03-23 AU AU31695/89A patent/AU3169589A/en not_active Abandoned
- 1989-03-23 GR GR890100185A patent/GR1000876B/el unknown
- 1989-03-23 GB GB8906758A patent/GB2219799B/en not_active Expired - Fee Related
- 1989-03-24 LU LU87489A patent/LU87489A1/xx unknown
- 1989-03-24 HU HU891515A patent/HUT50501A/hu unknown
- 1989-03-24 FR FR8903952A patent/FR2632321A1/fr not_active Withdrawn
- 1989-03-24 BE BE8900329A patent/BE1004202A5/fr not_active IP Right Cessation
- 1989-03-24 JP JP1073723A patent/JPH0279981A/ja active Pending
- 1989-03-24 KR KR1019890003761A patent/KR890014743A/ko not_active Withdrawn
- 1989-03-24 IT IT8919917A patent/IT1234961B/it active
- 1989-03-27 PT PT90118A patent/PT90118B/pt active IP Right Grant
- 1989-03-28 DE DE3910084A patent/DE3910084A1/de not_active Withdrawn
- 1989-03-28 CH CH1114/89A patent/CH681081A5/de not_active IP Right Cessation
-
1992
- 1992-12-04 AU AU29904/92A patent/AU2990492A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ228427A (en) | 1993-03-26 |
| FI891308A0 (fi) | 1989-03-20 |
| JPH0279981A (ja) | 1990-03-20 |
| SE8901031D0 (sv) | 1989-03-22 |
| NO891273D0 (no) | 1989-03-22 |
| FI891308A7 (fi) | 1989-09-25 |
| IE890950L (en) | 1989-09-24 |
| DK146789D0 (da) | 1989-03-22 |
| CH681081A5 (https=) | 1993-01-15 |
| DK146789A (da) | 1989-09-25 |
| FI891308L (fi) | 1989-09-25 |
| PT90118A (pt) | 1989-11-10 |
| SE8901031L (sv) | 1989-09-25 |
| DE3910084A1 (de) | 1989-11-16 |
| AU3169589A (en) | 1989-09-28 |
| GR890100185A (en) | 1990-01-19 |
| NL8900724A (nl) | 1989-10-16 |
| GB2219799A (en) | 1989-12-20 |
| FR2632321A1 (fr) | 1989-12-08 |
| ES2013408A6 (es) | 1990-05-01 |
| AU2990492A (en) | 1993-03-04 |
| GB2219799B (en) | 1992-10-14 |
| IT8919917A0 (it) | 1989-03-24 |
| PT90118B (pt) | 1994-07-29 |
| IL89673A0 (en) | 1989-09-28 |
| GB8906758D0 (en) | 1989-05-10 |
| LU87489A1 (fr) | 1989-10-26 |
| BE1004202A5 (fr) | 1992-10-13 |
| IT1234961B (it) | 1992-06-09 |
| GR1000876B (el) | 1993-03-16 |
| HUT50501A (en) | 1990-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Richmond et al. | Purification of melanoma growth stimulatory activity | |
| DE3584053D1 (de) | Gentechnologisches verfahren zur herstellung von hirudinen und mittel zur durchfuehrung dieses verfahrens. | |
| KR920701434A (ko) | 박테리아 및 이스트 내에서의 헤모글로빈 및 그의 동족체의 제조방법 | |
| RU2346951C2 (ru) | Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты) | |
| CA2264191A1 (en) | Recombinant toxin fragments | |
| Hoppe et al. | Preparation of biologically active platelet-derived growth factor type BB from a fusion protein expressed in Escherichia | |
| KR927003812A (ko) | 인자 viii:c 활성을 갖는 단백질 복합체 및 그의 제조 | |
| NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
| KR960704038A (ko) | 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek) | |
| WO1998023639A3 (en) | Shk toxin compositions and methods of use | |
| KR840001216A (ko) | 인간 혈청 알부민의 세균성 제품의 제조방법 | |
| KR870008028A (ko) | 생물학적으로 활성인단백질의 제조방법 | |
| NZ502391A (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| WO1996040915A3 (en) | Novel ctla4/cd28 ligands and uses therefor | |
| RU2003106809A (ru) | Гены гомологичных иммунодоминантных белков ehrlichia canis в 28-килодальтон и их применение | |
| DE69840174D1 (de) | Impfstoff das mit der abmagerungskrankheit von ferkeln assoziierten circovirus typ b vorbereitet wird | |
| MD2311F2 (en) | Obesity polypeptides, immunogenic fragment, analogue, human analogue and reduced human analogue, isolated molecule of nucleic acid, DNA molecule, detectable marked molecule of nucleic acid, vectors containing said DNA molecule, monoclonal antibody, polyclonal antibody and pharmaceutical composition for reduction of the animals body weight | |
| IL142905A (en) | Functional antagonists of hedgehog activity | |
| WO2000034474A3 (en) | Growth factor homolog zvegf3 | |
| JPS61502304A (ja) | ハイブリツド蛋白質及び遺伝子をコ−ドする融合遺伝子 | |
| CA2262756A1 (en) | A tumor necrosis factor related ligand | |
| KR870001311A (ko) | 단백질 및 폴리펩티드의 제조 방법 | |
| IL93397A (en) | Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens | |
| KR890014743A (ko) | 성장인자 활성을 가진 신규의 폴리펩티드 및 그 폴리펩티드를 코드화한 아미노산 배열 | |
| WO1999063086A3 (en) | Insulin-like growth factor binding protein-3 variants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19890324 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |